Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The concern is increasingly common on social media and online support groups
Why it matters for retatrutide: GLP-1 receptor agonists caused thyroid C-cell tumors in rodents, leading to a boxed warning
Canet G, et al
Cell Physiol Biochem (2019) 53:86586
Parker BA, Thompson PD
Last Published 10.31.2025 Effective Date: 11.01.2025 This policy addresses the use of Ilaris (canakinumab) for the treatment of cryopyrin-associated periodic syndromes (CAPS), tumor necrosis factor (TNF) receptor-associated periodic syndrome (TRAPS), hyperimmunoglobulin D (Hyper-IgD) syndrome (HIDS)/mevalonate kinase deficiency (MKD), familial mediterranean fever (FMF), Stills disease, systemic juvenile idiopathic arthritis (SJIA) and gout flares
US$ 20.80
US$ 23.45
US$ 28.40
US$ 22.34
US$ 24.71
